Literature DB >> 17543726

Osteoporosis in men.

Luigi Gennari1, John P Bilezikian.   

Abstract

Osteoporosis has long been considered to be a disease of the aging female skeleton. As awareness of the pervasiveness of this disorder increases, it is clear that men are also at risk for this disorder. Recent epidemiological studies have confirmed that osteoporosis in men is an increasing health problem. This development not only has its roots in increased longevity but also in increased awareness of this problem in men. The purpose of this article is to review what is known about the factors in men that lead to acquisition, maintenance, and loss of bone, as well as new insights about the causes, pathogenesis, and treatment of osteoporosis in men.

Entities:  

Mesh:

Year:  2007        PMID: 17543726     DOI: 10.1016/j.ecl.2007.03.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  24 in total

1.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.

Authors:  A Cohen; R R Recker; J Lappe; D W Dempster; S Cremers; D J McMahon; E M Stein; J Fleischer; C J Rosen; H Rogers; R B Staron; J Lemaster; E Shane
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

2.  A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy.

Authors:  C E Lee; W D Leslie; P Czaykowski; J Gingerich; M Geirnaert; Y K J Lau
Journal:  Curr Oncol       Date:  2011-08       Impact factor: 3.677

Review 3.  Idiopathic osteoporosis in men.

Authors:  Luigi Gennari; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

4.  Serratia marcescens osteomyelitis in Cushing's disease.

Authors:  Hugo F G Martins; Alexandra Raposo; Isabel Baptista; Julio Almeida
Journal:  BMJ Case Rep       Date:  2015-11-30

Review 5.  Strontium ranelate: an effective solution for diverse fracture risks.

Authors:  J D Ringe
Journal:  Osteoporos Int       Date:  2010-05-13       Impact factor: 4.507

6.  Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma.

Authors:  Jordi L Reverter; Eulàlia Colomé; Susana Holgado; Eva Aguilera; Berta Soldevila; Lourdes Mateo; Anna Sanmartí
Journal:  Endocrine       Date:  2010-04-16       Impact factor: 3.633

7.  Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients.

Authors:  J D Ringe; P Farahmand; E Schacht
Journal:  Rheumatol Int       Date:  2012-04-08       Impact factor: 2.631

Review 8.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

9.  Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.

Authors:  S D Nelson; R E Nelson; G W Cannon; P Lawrence; M J Battistone; M Grotzke; Y Rosenblum; J LaFleur
Journal:  Osteoporos Int       Date:  2014-07-19       Impact factor: 4.507

Review 10.  Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review.

Authors:  Mridul Datta; Gary G Schwartz
Journal:  Oncologist       Date:  2012-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.